Arvinas, Inc.

NasdaqGS:ARVN Stock Report

Market Cap: US$556.9m

Arvinas Future Growth

Future criteria checks 0/6

Arvinas's revenue and earnings are forecast to decline at 7.9% and 13.3% per annum respectively. EPS is expected to decline by 10.3% per annum. Return on equity is forecast to be -16.5% in 3 years.

Key information

-13.3%

Earnings growth rate

-10.3%

EPS growth rate

Pharmaceuticals earnings growth14.6%
Revenue growth rate-7.9%
Future return on equity-16.5%
Analyst coverage

Good

Last updated05 May 2025

Recent future growth updates

Recent updates

Arvinas, Inc.'s (NASDAQ:ARVN) Shares Bounce 37% But Its Business Still Trails The Industry

May 01
Arvinas, Inc.'s (NASDAQ:ARVN) Shares Bounce 37% But Its Business Still Trails The Industry
author-image

Phase III And PROTAC Data Will Advance Pipeline Despite Hurdles

Mar 24 Successful trials and partnerships in oncology could support Arvinas' transition to commercial operations, driving growth and revenue potential.

Arvinas: Veritac-2 ITT Failure Confirms Limited Prospects

Mar 14

Arvinas, Inc. (NASDAQ:ARVN) Not Doing Enough For Some Investors As Its Shares Slump 56%

Mar 12
Arvinas, Inc. (NASDAQ:ARVN) Not Doing Enough For Some Investors As Its Shares Slump 56%

Arvinas' Vepdegestrant: Why The Data May Not Hold Up

Dec 25

Arvinas (NASDAQ:ARVN) Is In A Good Position To Deliver On Growth Plans

Dec 24
Arvinas (NASDAQ:ARVN) Is In A Good Position To Deliver On Growth Plans

Investors Still Waiting For A Pull Back In Arvinas, Inc. (NASDAQ:ARVN)

Nov 28
Investors Still Waiting For A Pull Back In Arvinas, Inc. (NASDAQ:ARVN)

Arvinas: Major Catalyst Ahead, But Its History Gives Me Pause

Oct 16

Arvinas, Inc. (NASDAQ:ARVN) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Aug 02
Arvinas, Inc. (NASDAQ:ARVN) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Arvinas: Hugely Important Data Catalyst Upcoming - Success May Prove Elusive

Jul 12

Here's Why We're Watching Arvinas' (NASDAQ:ARVN) Cash Burn Situation

Jun 27
Here's Why We're Watching Arvinas' (NASDAQ:ARVN) Cash Burn Situation

Arvinas: Behind The Huge Rally

Mar 03

What Arvinas, Inc.'s (NASDAQ:ARVN) 28% Share Price Gain Is Not Telling You

Feb 25
What Arvinas, Inc.'s (NASDAQ:ARVN) 28% Share Price Gain Is Not Telling You

News Flash: Analysts Just Made A Notable Upgrade To Their Arvinas, Inc. (NASDAQ:ARVN) Forecasts

Aug 13
News Flash: Analysts Just Made A Notable Upgrade To Their Arvinas, Inc. (NASDAQ:ARVN) Forecasts

There's Reason For Concern Over Arvinas, Inc.'s (NASDAQ:ARVN) Price

May 05
There's Reason For Concern Over Arvinas, Inc.'s (NASDAQ:ARVN) Price

Earnings and Revenue Growth Forecasts

NasdaqGS:ARVN - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2027156-270-263-26114
12/31/2026162-253-283-28718
12/31/2025282-105-171-17818
3/31/2025427-47-253-251N/A
12/31/2024263-199-261-259N/A
9/30/2024161-309-260-258N/A
6/30/202493-323-217-215N/A
3/31/202471-355-356-354N/A
12/31/202379-367-351-348N/A
9/30/2023159-295-340-336N/A
6/30/2023158-298-323-318N/A
3/31/2023137-301-313-308N/A
12/31/2022131-282-280-273N/A
9/30/2022127-253-246-238N/A
6/30/2022103-233503510N/A
3/31/202275-213536541N/A
12/31/202154-191555559N/A
9/30/202123-180562566N/A
6/30/202121-164-142-138N/A
3/31/202121-139-118-112N/A
12/31/202026-119-96-90N/A
9/30/202024-99-83-77N/A
6/30/202047-86-59-53N/A
3/31/202045-78-52-45N/A
12/31/201943-70-47-41N/A
9/30/201942-65-42-37N/A
6/30/201915-173-54-50N/A
3/31/201914-179-51-48N/A
12/31/201814-240N/A-16N/A
9/30/201813-233N/A24N/A
6/30/201812-114N/A28N/A
3/31/201810-98N/A31N/A
12/31/20178-29N/A5N/A
12/31/20167-12N/A-19N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ARVN is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: ARVN is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: ARVN is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: ARVN's revenue is expected to decline over the next 3 years (-7.9% per year).

High Growth Revenue: ARVN's revenue is forecast to decline over the next 3 years (-7.9% per year).

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ARVN is forecast to be unprofitable in 3 years.

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/06 19:38
End of Day Share Price 2025/05/06 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Arvinas, Inc. is covered by 31 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Peter LawsonBarclays
null nullBMO Capital Markets Equity Research
Evan SeigermanBMO Capital Markets Equity Research